SCORPIUS HOLDINGS, INC.

Analyst Reco. Scorpius Holdings, Inc.

Equities

SCPX

US42237K4094

Market Closed - Nyse Other stock markets 01:30:00 21/05/2024 am IST			5-day change	1st Jan Change
0.16 ^USD	+54.59%		-11.85%	-63.66%

14/05	Top Midday Decliners	MT
01/05	Scorpius Holdings, Inc. announced that it expects to receive $0.75 million in funding	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Brookline Capital Downgrades NightHawk Biosciences to Hold From Buy	01/23/01	MT
Maxim Downgrades NightHawk Biosciences to Hold From Buy	03/23/03	MT
B. Riley Lowers Heat Biologics' PT to $8 from $10, Adjusts Model for Higher Cost of Capital to Support Higher Operating Expenditures Ramp; Keeps Buy Rating	18/22/18	MT
Alliance Global Adjusts Heat Biologics' Price Target to $15.50 From $20, Reiterates Buy Rating	15/22/15	MT
B. Riley Lowers Heat Biologics' Price Target to $10 from $15 After Revising Cost Capital Assumptions, Keeps Buy Rating	24/22/24	MT
HEAT BIOLOGICS : Alliance Global Adjusts Price Target on Heat Biologics to $20 From $32, Reiterates Buy Rating	25/21/25	MT
HEAT BIOLOGICS : B. Riley Lowers Heat Biologics' PT to $15 from $20 to Reflect Increased Research and Development Investment, Keeps Buy Rating	18/21/18	MT
HEAT BIOLOGICS : Cantor Fitzgerald Starts Heat Biologics at Overweight With $22 Price Target	03/21/03	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.

BENEFIT NOW